Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge

Stephen Lafranchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.

Original languageEnglish (US)
Pages (from-to)115-116
Number of pages2
JournalUS Endocrinology
Volume10
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Congenital Hypothyroidism
Public Health
Costs and Cost Analysis
Developed Countries
Parturition
Population

Keywords

  • Congenital hypothyroidism
  • Cost-benefit
  • Neonates
  • Newborn screening
  • Thyroid-stimulating hormone (TSH)
  • Thyroxine (T4)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge. / Lafranchi, Stephen.

In: US Endocrinology, Vol. 10, No. 2, 2014, p. 115-116.

Research output: Contribution to journalArticle

@article{b8eeadc61d2948bc82b59ed73ffadc56,
title = "Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge",
abstract = "Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 {\%} of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.",
keywords = "Congenital hypothyroidism, Cost-benefit, Neonates, Newborn screening, Thyroid-stimulating hormone (TSH), Thyroxine (T4)",
author = "Stephen Lafranchi",
year = "2014",
doi = "10.17925/USE.2014.10.02.115",
language = "English (US)",
volume = "10",
pages = "115--116",
journal = "US Endocrinology",
issn = "1758-3918",
publisher = "Touch Briefings",
number = "2",

}

TY - JOUR

T1 - Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge

AU - Lafranchi, Stephen

PY - 2014

Y1 - 2014

N2 - Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.

AB - Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.

KW - Congenital hypothyroidism

KW - Cost-benefit

KW - Neonates

KW - Newborn screening

KW - Thyroid-stimulating hormone (TSH)

KW - Thyroxine (T4)

UR - http://www.scopus.com/inward/record.url?scp=84987990626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987990626&partnerID=8YFLogxK

U2 - 10.17925/USE.2014.10.02.115

DO - 10.17925/USE.2014.10.02.115

M3 - Article

AN - SCOPUS:84987990626

VL - 10

SP - 115

EP - 116

JO - US Endocrinology

JF - US Endocrinology

SN - 1758-3918

IS - 2

ER -